Description

BPC-157 and TB-500 are synthetic peptides widely studied in laboratory research focused on cellular signaling and structural protein regulation. This dual-peptide formulation is utilized to examine coordinated peptide activity in experimental models investigating tissue-related molecular pathways.

Biochemical Characteristics

BPC-157 is a stable pentadecapeptide studied for its interaction with growth-related signaling pathways. TB-500 is a thymosin beta-4 analog associated with actin-binding and cytoskeletal organization. Together, they are examined for peptide-mediated influence on cellular structural dynamics and signaling processes.

Research Applications

This peptide combination is utilized in research models investigating angiogenesis-associated pathways, actin polymerization dynamics, extracellular matrix regulation, and cellular migration mechanisms under controlled laboratory conditions.

Pathway / Mechanistic Context

Mechanistic research focuses on actin filament modulation, growth factor signaling interactions, and peptide-mediated regulation of cytoskeletal organization and cellular communication pathways.

Preclinical Research Summary

Preclinical investigations have evaluated BPC-157 and TB-500 in in vitro and experimental models to better understand peptide-driven structural signaling and tissue-associated molecular processes.

Form & Analytical Testing

BPC-157 and TB-500 are supplied as lyophilized peptides and undergo analytical verification, including HPLC testing, to confirm identity, purity, and composition consistency for laboratory research use.

RUO Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.